JPMorgan Chase & Co’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.6M | Sell |
|
|||||
|
2025
Q1 | $12.7M | Buy |
|
|||||
|
2024
Q4 | $14.5M | Sell |
|
|||||
|
2024
Q3 | $22.8M | Sell |
|
|||||
|
2024
Q2 | $28.3M | Sell |
|
|||||
|
2024
Q1 | $27.4M | Sell |
|
|||||
|
2023
Q4 | $47.6M | Buy |
|
|||||
|
2023
Q3 | $40.9M | Sell |
|
|||||
|
2023
Q2 | $43.8M | Buy |
|
|||||
|
2023
Q1 | $37.8M | Buy |
|
|||||
|
2022
Q4 | $36.6M | Buy |
|
|||||
|
2022
Q3 | $41.1M | Sell |
|
|||||
|
2022
Q2 | $38.5M | Sell |
|
|||||
|
2022
Q1 | $43.8M | Sell |
|
|||||
|
2021
Q4 | $38.6M | Sell |
|
|||||
|
2021
Q3 | $81M | Buy |
|
|||||
|
2021
Q2 | $90.8M | Buy |
|
|||||
|
2021
Q1 | $88.3M | Buy |
|
|||||
|
2020
Q4 | $106M | Buy |
|
|||||
|
2020
Q3 | $35.3M | Buy |
|
|||||
|
2020
Q2 | $30.6M | Buy |
|
|||||
|
2020
Q1 | $12.8M | Sell |
|
|||||
|
2019
Q4 | $32.4M | Buy |
|
|||||
|
2019
Q3 | $12.9M | Buy |
|
|||||
|
2019
Q2 | $11.6M | Buy |
|
|||||
|
2019
Q1 | $978K | Sell |
|
|||||
|
2018
Q4 | $8.04M | Buy |
|
|||||
|
2018
Q3 | $541K | Sell |
|
|||||
|
2018
Q2 | $480K | Buy |
|
|||||
|
2018
Q1 | $240K | Sell |
|
|||||
|
2017
Q4 | $3.12M | Sell |
|
|||||
|
2017
Q3 | $3.29M | Buy |
|
|||||
|
2017
Q2 | $92K | Buy |
|
|||||
|
2017
Q1 | $37K | Sell |
|
|||||
|
2016
Q4 | $61K | Sell |
|
|||||
|
2016
Q3 | $177K | Sell |
|
|||||
|
2016
Q2 | $1.12M | Buy |
|
|||||
|
2016
Q1 | $346K | Buy |
|
|||||
|
2015
Q4 | $123K | Sell |
|
|||||
|
2015
Q3 | $478K | Sell |
|
|||||
|
2015
Q2 | $2.42M | Sell |
|
|||||
|
2015
Q1 | $22M | Sell |
|
|||||
|
2014
Q4 | $22.6M | Buy |
|
|||||
|
2014
Q3 | $13.9M | Buy |
|
|||||
|
2014
Q2 | $9.07M | Sell |
|
|||||
|
2014
Q1 | $15.4M | Buy |
|
|||||
|
2013
Q4 | $589K | Sell |
|
|||||
|
2013
Q3 | $2.22M | Sell |
|
|||||
|
2013
Q2 | $2.96M | Buy |
|